JESSICA GORHAM: Open Payments
NPI 1164018834 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$977 in 36 payments from 15 companies in 2025. Trend: 2023 $220 · 2024 $576 · 2025 $977
Food & beverage: $977
| Company | Payments | Amount |
|---|---|---|
| Pharmacosmos Therapeutics Inc. | 2 | $233 |
| AstraZeneca Pharmaceuticals LP | 6 | $161 |
| ABBVIE INC. | 7 | $143 |
| Janssen Biotech, Inc. | 4 | $88 |
| Celgene Corporation | 3 | $53 |
| Exelixis Inc. | 2 | $45 |
| Astellas Pharma US Inc | 2 | $41 |
| PFIZER INC. | 2 | $39 |
| ARRAY BIOPHARMA INC | 2 | $38 |
| Genentech USA, Inc. | 1 | $28 |
Products named: MONOFERRIC, EPKINLY, IMFINZI, TAGRISSO, REBLOZYL, CABOMETYX, TECVAYLI, MEKTOVI.
Industry payments across ME — which companies pay providers there.
